Skip to main content

Featured

Alberta Separation Dream Stalls: What the Court Ruling Means for Your Wallet and Canada's Future

                                                                                               Alberta Legislature Building, Edmonton.  A judge has killed Alberta’s separation referendum petition, citing a failure to consult First Nations. Premier Danielle Smith vows to appeal — but the path forward is murky, and the economic stakes for all Canadians are enormous. MoneySavings.ca Staff  •  May 15, 2026  •  6 min read For much of the past year, Alberta separatists believed they were on the cusp of a historic moment. The grassroots group Stay Free Alberta had gathered over 301,000 petition signatures — well above the 178,000 required — and Premier Danielle Smith had already booked Oct...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment